HIP
SYNH

Hatteras Investment Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Hatteras Investment Partners’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,065
Closed -$319K – 26
2016
Q4 		$319K Sell
6,065
-7,795
-56% -$377K 1.86% 23
2016
Q3 		$618K Sell
13,860
-3,750
-21% -$163K 2.12% 15
2016
Q2 		$671K Buy
+17,610
New +$774K 3.75% 7

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Hatteras Investment Partners's SYNH Position: Q1 2017 in Review

Hatteras Investment Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2017, closing a stake of 6,065 shares — an estimated $319K sold.

Hatteras Investment Partners first reported a position in SYNH in Q2 2016 and held it in 3 quarters. The position peaked at $671K in Q2 2016. 232 funds tracked by Wall St. Rank hold SYNH as of Q1 2017.

  • Hatteras Investment Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2017 after selling out during the quarter.
  • Hatteras Investment Partners sold 6,065 Syneos Health, Inc. Class A Common Stock shares in Q1 2017, an estimated $319K.
  • Hatteras Investment Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 3 quarters.
  • Hatteras Investment Partners's Syneos Health, Inc. Class A Common Stock position peaked at $671K in Q2 2016.
  • 232 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2017.

Based on Hatteras Investment Partners's 13F filing for Q1 2017.